Videos / Recombinant respiratory syncytial virus pre-fusion F protein vaccine

Product Explainer

Recombinant respiratory syncytial virus pre-fusion F protein vaccine

Description

In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).

Additional resources

NCIRS FAQ: Respiratory syncytial virus (RSV) FAQs | NCIRS.
NCIRS Fact Sheet – state funding of Nirsevimab, eligibility criteria by state: State and territory nirsevimab program summary 2025.pdf

NEXT LIVE Webcast

Days

Hours

Minutes

Seconds

Dr Chrys Pulle

Practical Strategies for Behaviour Management in Dementia

A/Prof Michael Woodward AM

The New Pneumococcal Vaccination for Older Adults – What You Need to Know

Prof Rodney Baber AM

Adolescent Contraception – Common Myths

Dr Jo-Ann See

Acne Practical Cases – Trunk, Skin of Colour

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

07 July 2026

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Product Explainer

Recombinant respiratory syncytial virus pre-fusion F protein vaccine